Stable hydrate of a muscarinic receptor antagonist

Details Stable hydrate of a muscarinic receptor antagonist Stable hydrate of a muscarinic receptor antagonist

2005-08-16

2005-08-16

Shameem, Golam M M (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C549S429000, C549S456000, C549S462000, C549S467000, C378S070000, C548S400000, C548S517000

Reexamination Certificate

active

06930188

ABSTRACT:
A stable solid hydrate of a muscarinic receptor antagonist is useful in the treatment of irritable bowel syndrome, diverticular disease, oesophageal achalasia, chronic obstructive airways disease, over active bladder (including symptoms of incontinence, urge and frequency), urinary incontinence, neurogenic urinary urgency or pollakiuria, treatment of bladder functional disorder, urinary leakage, painful or difficult urination caused by neurogenic bladder, spastic or hypertonic bladder, dysfunctional bladder syndrome, gastrointestinal disorders including gastrointestinal hyperactivity, and relaxing effect on intestinal smooth muscle cells.

REFERENCES:
patent: 5096890 (1992-03-01), Cross et al.
patent: 5233053 (1993-08-01), Cross et al.
patent: 5837724 (1998-11-01), Allen et al.
patent: 6106864 (2000-08-01), Dolan et al.
patent: 0388054 (1993-11-01), None

Affiliated with

Also associated with

Rating

Stable hydrate of a muscarinic receptor antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stable hydrate of a muscarinic receptor antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable hydrate of a muscarinic receptor antagonist will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3443941